ProtoKinetix, Inc.
ProtoKinetix, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Cash Equivalents At Carrying Value | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Current | |||||||||||||||||
Assets Current | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Finite Lived Intangible Assets Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | |||||||||||||||||
Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accounts Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | |||||||||||||||||
Additional Paid In Capital | 49 | 49 | 49 | 49 | 49 | 48 | 48 | 48 | 48 | 48 | 48 | 48 | |||||
Stockholders Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Retained Earnings Accumulated Deficit | -49 | -48 | -48 | -48 | -48 | -48 | -48 | -48 | -48 | -48 | -48 | -47 | |||||
Liabilities And Stockholders Equity | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | |||||
Common Stock Shares Issued | 390 | 389 | 385 | 372 | 367 | 361 | 350 | 346 | 339 | 336 | 327 | 323 | |||||
Shares Outstanding | 390 | 389 | 385 | 372 | 367 | 361 | 350 | 346 | 339 | 336 | 327 | 323 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -9.10% | -12.00% | -46.00% | -12.97% | -3.48% | 15.82% | -28.57% | -7.14% | 41.43% | - | - | - |
| 2024 | -9.94% | -34.13% | -16.35% | -21.28% | -1.42% | -21.84% | 21.00% | 11.11% | 5.56% | -7.14% | -36.79% | -37.86% |
| 2023 | -11.24% | -11.66% | -8.13% | 4.23% | 13.71% | -3.23% | 34.62% | 29.08% | 53.85% | -23.62% | -17.59% | -24.42% |
| 2022 | - | - | - | - | - | - | - | - | - | 7.14% | 0.00% | -8.64% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | - | - | - | - | 0.08 | 0.06 | 0.06 | 0.48 | 1.07 | 1.49 | 0.15 | 0.64 | |||||
| Quick Ratio | - | - | - | - | 0.06 | 0.04 | 0.04 | 0.46 | 0.99 | 1.41 | 0.13 | 0.62 | |||||
| Working Capital | - | - | - | - | -81.01K | -55.52K | -63.68K | -23.24K | 884.00 | 6.45K | -45.01K | -14.93K | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.91 | 0.46 | 0.40 | 0.36 | 0.22 | 0.14 | 0.17 | 0.10 | 0.03 | 0.03 | 0.13 | 0.10 | |||||
| Debt Ratio | - | - | - | - | 0.18 | 0.12 | 0.15 | 0.09 | 0.03 | 0.03 | 0.12 | 0.09 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | - | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | |||||
| Free Cash Flow Per Share TTM | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Growth Metrics | |||||||||||||||||
| Net Income Growth (1Y) | 0.54% | 1.59% | -7.64% | -12.35% | -57.51% | -68.38% | -73.24% | -78.22% | -48.81% | -57.48% | -44.85% | -18.12% | |||||
| EPS Growth (1Y) | -5.81% | 1.59% | -17.78% | -18.57% | -60.91% | -70.02% | -73.86% | -79.90% | -55.62% | -63.14% | -48.51% | -20.78% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -5.69 | -8.19 | -12.24 | -9.85 | -10.43 | -9.57 | -16.47 | -15.23 | -9.15 | -6.98 | -6.31 | -4.29 | |||||
| P/B TTM | 8.55 | 9.47 | 12.03 | 10.48 | 9.97 | 8.53 | 16.75 | 14.52 | 18.38 | 18.00 | 23.94 | 19.41 | |||||
| Market Cap | 2.14M | 3.08M | 4.53M | 3.59M | 3.90M | 3.54M | 6.60M | 6.33M | 8.06M | 8.17M | 9.44M | 8.18M | |||||
| Enterprise Value | 2.14M | 3.08M | 4.48M | 3.59M | 3.90M | 3.54M | 6.59M | 6.31M | 8.04M | 8.15M | 9.43M | 8.15M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -222.58K | -269.59K | -291.36K | -281.11K | -332.71K | -347.46K | -404.11K | -435.14K | -537.82K | -666.68K | -693.44K | -936.72K | |||||
| Net Debt | -607.00 | -112.00 | -49.48K | 0.00 | -5.69K | -2.20K | -2.84K | -20.41K | -12.40K | -18.66K | -6.94K | -25.55K | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
ProtoKinetix, Inc. (PKTX) — SEC Financial Statements & Analysis
ProtoKinetix, Inc. (PKTX) is a pharmaceutical preparations company, incorporated in NV. ProtoKinetix, Inc. trades on OTC as: PKTX. Based on its latest SEC filing (Form 10-Q, period ending 2025-09-30), ProtoKinetix, Inc. reported a Debt-to-Equity ratio of 0.91x, a Price-to-Book (P/B) ratio of 8.55x (TTM), at a market cap of $2.14M. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- 0.91x
- P/B TTM
- 8.55x
- Market Cap
- $2.14M
Data as of 2025-09-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is ProtoKinetix, Inc. in?
ProtoKinetix, Inc. (PKTX) operates in the Pharmaceutical Preparations industry.
What is PKTX's market cap?
ProtoKinetix, Inc. (PKTX) has a market capitalization of $2.14M as of 2025-09-30.
What exchange does PKTX trade on?
ProtoKinetix, Inc. (PKTX) trades on the OTC.
Where is ProtoKinetix, Inc. incorporated?
ProtoKinetix, Inc. is incorporated in NV.